Mads and Smads in TGFβ signalling

Current Opinion in Cell Biology

Volumn 10, Issue 2, 1998, Pages 188-194

  Attisano, Liliana ^a   Wrana, Jeffrey L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; CANCER; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE ISOLATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032054574     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(98)80141-5     Document Type: Article

References (65)

1. Raftery LA, Twombly V, Wharton K, Gelbart WM. Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila. Genetics. 139:1995;241-254.
2. Sekelsky JJ, Newfeld SJ, Raftery LA, Chartoff EH, Gelbart WM. Genetic characterization and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics. 139:1995;1347-1358.
3. Hoodless PA, Haerry T, Abdollah S, Stapleton M, O'Connor MB, Attisano L, Wrana JL. MADR1, a MAD-related protein that functions in BMP2 signalling pathways. Cell. 85:1996;489-500.
4. Wiersdorff V, Lecuit T, Cohen SM, Mlodzik M. Mad acts downstream of Dpp receptors, revealing a differential requirement for dpp signalling and propagation of morphogenesis in the Drosophila eye. Development. 122:1996;2153-2162.
5. Newfeld SJ, Chartoff EH, Graff JM, Melton DA, Gelbart WM. Mothers against dpp encodes a conserved cytoplasmic protein required in DPP/TGFβ responsive cells. Development. 122:1996;2099-2108.
6. Savage C, Das P, Finelli A, Townsend S, Sun C, Baird S, Padgett R. The C. elegans sma-2, sma-3 and sma-4 genes define a novel conserved family of TGF-β pathway components. Proc Natl Acad Sci USA. 93:1996;790-794.
7. Shi Y, Hata A, Lo RS, Massagué J, Pavletich NP. A structural basis for mutational inactivation of the tumour suppressor Smad4. of special interest Nature. 388:1997;87-93 This paper describes the crystal structure of the MH2 domain, thus providing a look at the three-dimensional structure of a domain conserved in all Smad family members.
8. Baker JC, Harland R. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev. 10:1996;1880-1889.
9. Hata A, Lo RS, Wotton D, Lagna G, Massagué J. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature. 388:1997;82-87.
10. Meersseman G, Verschueren K, Nelles L, Blumenstock C, Kraft H, Wuytens G, Remacle J, Kozak CA, Tylzanowski P, Niehrs C, Huylebroeck D. The C-terminal domain of Mad-like signal transducers is sufficient for biological activity in the Xenopus embryo and transcription activation. Mech Dev. 61:1997;127-140.
11. Wu R-Y, Zhang Y, Feng X-H, Derynck R. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol Cell Biol. 17:1997;2521-2528.
12. Zhang Y, Musci T, Derynck R. The tumor suppressor Smad4/DPC4 as a central mediator of Smad function. Curr Biol. 7:1997;270-276.
13. de Caestecker MP, Hemmati P, Larisch-Bloch S, Ajmera R, Roberts AB, Lechleider RJ. Characterization of functional domains with Smad4/DPC4. J Biol Chem. 272:1997;13690-13696.
14. Rotin D. WW (WWP) domains: from structure to function. Pawson A.S. Current Topics in Microbiology and Immunology. 228:1997;115-133 Springer-Verlag, Berlin.
15. Chen Y, Bhushan A, Vale W. Smad8 mediates the signalling of the receptor serine kinase. Proc Natl Acad Sci USA. 94:1997;12938-12943.
16. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui L-C, Bapat B, Gallinger S, Andrulis I, et al. MADR2 maps to 18q21 and encodes a TGFβ MAD-related protein that is functionally mutated in colorectal carcinoma. Cell. 86:1996;543-552.
17. Kretzschmar M, Liu F, Hata A, Doody J, Massagué J. The TGF-β family mediator Smad 1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev. 11:1997;984-995.
18. Lechleider R, De Caestecker MP, Dehejia A, Polymeropoulos MH, Roberts AB. Serine phosphorylation, chromosomal localization and transforming growth factor-β signal transduction by human bsp-1. J Biol Chem. 271:1996;17617-17620.
19. Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA, Lodish HF. Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci USA. 94:1997;10669-10764.
20. Nakao A, Rsijer E, Imamura T, Souchelnytskyi S, Stenman G, Heldin C-H, ten Dijke P. Identification of Smad2, a human Mad-related protein in the transforming growth factor β is signaling pathway. J Biol Chem. 272:1997;2896-2900.
21. Yingling JM, Das P, Savage C, Zhang M, Padgett RW, Wang X-F. Mammalian Dwarfins are phosphorylated in response to TGF-β and are implicated in control of cell growth. Proc Natl Acad Sci USA. 93:1996;8940-8944.
22. Zhang Y, Feng X-H, Wu R-Y, Derynck R. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. of special interest Nature. 383:1996;168-172 This paper demonstrates for the first time that a receptor-regulated Smad, Smad3, synergistically interacts with Smad4 to mediate TGFβ signalling. A direct interaction of Smad3 with the TGFβ receptor complex is also demonstrated.
23. Liu F, Hata A, Baker J, Doody J, Cárcamo J, Harland R, Massagué J. A human Mad protein acting as BMP-regulated transcriptional activator. Nature. 381:1996;620-623.
24. Maclas-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL. MADR2 is substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signalling. of outstanding interest Cell. 87:1996;1215-1224 This paper demonstrated that Smads are substrates of the type I receptor, identified the SSXS motif as the target of phosphorylation and showed that phosphorylation at this site was required to induce nuclear accumulation of Smads. This work defined the role of receptor-regulated Smads in transmitting signals directly from the receptor kinase into the nucleus.
25. Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J-I, Heldin C-H, Miyazono K, et al. TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16:1997;5353-5362.
26. Newfeld SJ, Mehra A, Singer MA, Wrana JL, Attisano L, Gelbart WM. Mothers against dpp participates in a DPP/TGF-β responsive serine-threonine kinase signal transduction cascade. Development. 124:1997;3167-3176.
27. Graff JM, Bansal A, Melton DA. Xenopus Mad porteins transduce distinct subsets of signals for the TGFβ superfamily. of outstanding interest Cell. 85:1996;479-487 This paper showed that expression of Smad1 and Smad2 in Xenopus oocytes leads to distinct biological responses associated with BMP and TGFβ/activin respectively, thus providing the first indication the Smads provide specificity in signalling by the TGFβ superfamily.
28. Suzuki A, Chang C, Yingling J, Wang X-F, Hemmati-Brivanlou A. Smad5 induces ventral fates in Xenopus embryo. Dev Biol. 184:1997;402-405.
29. Thomsen GH. Xenopus mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP2/4 receptor. Development. 122:1996;2359-2366.
30. Abdollah S, Maclas-Silva M, Tsukazaki T, Hayashi H, Attisano L, Wrana JL. Tβ R1 phosphorylation of Smad2 on Ser 465 and 467 is required for Smad2/Smad4 complex formation and signalling. J Biol Chem. 272:1997;27678-27685.
31. 467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling. J Biol Chem. 272:1997;28107-28115.
32. Feng X-H, Derynck R. A kinase subdomain of transforming growth factor-β (TGF-β) type 1 receptor determines the TGF-β intracellular signaling specificity. EMBO J. 16:1997;3912-3923.
33. Lagna G, Hata A, Hemmati-Brivanlou A, Massagué J. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. of outstanding interest Nature. 383:1996;832-836 This paper demonstrates biochemically and biologically, using a Xenopus assay, that Smad4 is an essential mediator of both TGFβ/activin and BMP signals. The authors show that Smad4 forms heteromeric complexes with Smad1 and Smad2 and thus may function as a common mediator of all TGFβ superfamily signals.
34. Liu F, Pouponnot C, Massagué J. Dual role of the Smad4/DPC4 tumor suppressor in TGFβ-inducible transcriptional complexes. Genes Dev. 11:1997;3157-3167.
35. Candia AF, Watabe T, Hawley SB, Onichtchouk D, Zhang Y, Derynck R, Niehrs C, Cho KY. Cellular interpretation of multiple TGF-β signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signalling mediated by Smads. Development. 124:1997;4467-4480.
36. Chen X, Rubock MJ, Whitman M. A transcriptional partner for MAD proteins in TGF-β signalling. of outstanding interest Nature. 383:1996;691-696 This paper describes the identification of a novel forkhead-containing transcription factor from Xenopus, named and FAST1. FAST1 was shown to bind to an activin-rsponse element in the Mix.2 promoter and form a transcriptional activation complex, together with Smad2. Thus, it is the first demonstration of a nuclear target for Smad2.
37. Chen X, Weisberg E, Fridmacher V, Watanabe M, Naco G, Whitman M. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature. 389:1997;85-89.
38. Howell M, Hill C. XSmad2 directly activates the activin-inducible dorsal mesoderm gene XFKH1 in Xenopus embryos. EMBO J. 16:1997;7411-7421.
39. Kim J, Johnson K, Chen HJ, Carroll S, Laughon A. Drosophila Mad binds to DNA and directly mediates activation of vestigial by decapentaplegic. of special interest Nature. 388:1997;304-308 This paper characterized a Dpp-responsive element in the quadrant enhancer of the vestigial gene and showed that the MH1 domain of Mad can directly bind to the element. Mutations that block binding of Mad prevented activation of the element in vivo, thereby poviding evidence that Smads can directly bind DNA to activate transcription.
40. Eresh S, Riese J, Jackson DB, Bohmann D, Bienz M. A CREB-binding site as a target for decapentaplegic signalling during Drosophila endoderm induction. EMBO J. 16:1997;2014-2022.
41. Yingling JM, Datto MB, Wong C, Frederick JP, Liberati NT, Wang X-F. Tumour suppressor Smad4 is a tansforming growth factor β-inducible DNA binding protein. Mol Cell Biol. 17:1997;7019-7028.
42. Wilson PA, Lagna G, Suzuki A, Hemmati-Brivanlou A. Concentration-dependent patterning of the Xenopus ectoderm by BMP4 and its signal transducer Smad1. Development. 124:1997;3177-3184.
43. Li M, Li J, Hoodless PA, Tzukazaki T, Wrana JL, Attisano L, Tsang BK. MADR2 Expression in avian granulosa cells is up-regulated by TGFβ during ovarian follicular development. Endocrinology. 138:1997;3659-3665.
44. Kretzchmar M, Doody J, Massagué J. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature. 389:1997;618-622.
45. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu Y-Y, Grinnell BW, Richardson MA, Topper JN, Gimbrone JMA, Wrana JL, Falb D. The MAD-related protein Smad7 associates with the TGFb receptor and functions as an antagonist of TGFβ signalling. of outstanding interest Cell. 89:1997;1165-1173 See note to Nakano., 1997 [47].
46. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J-I, Kawabata M, Miyazono K. Smad6 inhibits signalling by the TGF-β superfamily. of outstanding interest Nature. 389:1997;622-626 See note to Nakano., 1997 [47].
47. Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin N-E, Heldin C-H, ten Dijke P. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling. of outstanding interest Nature. 389:1997;631-635 These three papers define a novel class of Smad proteins. Unlike the positively acting Smads, the inhibitory Smads identified in these papers function to block TGFβ and BMP signalling by directly interacting with the receptors to prevent association and phosphorylation of the receptor-regulated Smads.
48. Topper JN, Cai J, Qiu Y, Anderson KR, Xu Y-Y, Deeds JD, Feeley R, Gimeno CJ, Woolf EA, Tayber O, et al. Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc Natl Acad Sci USA. 94:1997;9314-9319.
49. Riggins GJ, Kinzler KW, Vogelstein B, Thiagalingam S. Frequency of Smad gene mutations in human cancers. Cancer Res. 57:1997;2578-2580.
50. Tsuneizumi K, Nakayama T, Kamoshida Y, Kornberg TB, Christian JL, Tabata T. Daughters against dpp modulates dpp organizing activity in Drosophila wing development. Nature. 389:1997;627-631.
51. Patterson G, Koweek A, Wong A, Liu Y, Ruvkun G. The DAF-3 Smad protein antagonizes TGF-β-related receptor signalling in the C. elegans dauer pathway. Genes Dev. 11:1997;2679-2690.
52. Green JBA, Smith JC. Graded changes in dose of a Xenopus activin A homologue elicit stepwise transition in embryonic cell fate. Nature. 347:1990;391-394.
53. Markowitz S, Wang J, Myeroff L, Parsons R, Sun LZ, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science. 268:1995;1336-1338.
54. Kinzler KW, Vogelstein B. Lessons from the hereditary colorectal cancer. Cell. 87:1996;159-170.
55. Myeroff LL, Parsons R, Kim S-J, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J, Park K, et al. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res. 55:1995;5545-5547.
56. Garrigue-Antar L, Muoz-Antonia T, Antonia SJ, Gesmonde J, Vellucci VF, Reiss M. Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res. 55:1995;3982-3987.
57. Markowitz SD, Roberts AB. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev. 7:1996;93-102.
58. Rustgi AK. MAD about colorectal cancer. Gastroenterology. 111:1996;1387-1389.
59. Hahn SA, Schutte M, Shamsul Hoque ATM, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. of outstanding interest Science. 271:1996;350-353 This paper describes the first mammalian Smad gene, Smad4, demonstrates its localization at 18q21 and shows that it is mutated in pancreatic carcinomas. This paper is significant because it defines Smads as a novel class of tumour suppressors that is involved in the development of human cancers.
60. Riggins GJ, Thiagalingam S, Rozemblum E, Weinstein CL, Kern SE, Hamilton SR, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B. MAD-related genes in the human. Nat Genet. 13:1996;347-349.
61. Thiagalingam S, Lengauer C, Leach F, Schutte M, Hahn S, Overhauser J, Willson J, Markowitz S, Hamilton S, Kern S, et al. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet. 13:1996;343-346.
62. Takagi Y, Kohmura H, Futamura M, Kida H, Tanemura H, Shimokawa K, Saji S. Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology. 111:1996;1369-1372.
63. Nagatake M, Takagi Y, Osada H, Uchida K, Mitsudomi T, Saji S, Shimokata K, Takahashi T. Somatic in vivo alteration of the DPC4 gene at 18q21 in human lung cancers. Cancer Res. 56:1996;2718-2720.
64. Wisotzkey RG, Mehra A, Sutherland DJ, Dobens LL, Liu X, Dohrmann C, Attisano L, Raftery LA. Medes, a Drosophila Smad4 homolog that is differentially required to potentiate DPP responses. Development. 1998;. in press.
65. Hata A, Lagna G, Massague J, Hemmati-Brivanlou A. Smad6 inhibits BMP/Smad 1 signalling by specifically competing wth the Smad4 tumour suppressor. Genes Dev. 12:1998;186-197.